Among disparate infectious diseases viral infection in particular challenges survival of mankind across the globe. By superseding those events, 2019 novel (CoVID-19) or SARS-CoV-2 has become a new human health crisis threatening the world. Corona viruses (CoV) are large family of viruses that affects birds and mammals. In humans, Corona virus can cause respiratory tract infection ranging from the common cold to more serious infection such as SARS (Severe acute respiratory syndrome), MERS (Middle East Respiratory Syndrome) and CoVID-19 (Corona Virus Disease 2019) which can also become lethal. The Novel corona virus (CoVID-19) originated in 2019, is a novel virus which has not been identified in humans since past. At present, the source of CoVID-19 is not known. Although the infection is presumed to be in origin, person to person transmission is evident. Many supportive and symptomatic therapies where being carried out by the Medical practitioners as per the instructions of World Health Organization (WHO) with a hypothesis and there is no evidence that it works against CoVID-19. best to lower the current crises of infection is prevention and many measures that boosts the immunity are following by the people as directed by the Ministry of AYUSH.

In this developing scientific and medical world there is a keen curiosity in studying the activity of human gut micro flora in the emerging revolutionary medical process, fecal microbiota transplantation. This process is about the incorporation of prepared fecal matter solution from the donor into the recipient’s gut which is mainly done to restore and alter the microbial content in the gut of the recipient and to attain a therapeutic impact with greater health benefit. FMT, a bacteriotherapy has proved itself by successfully treating the recurrent clostridium difficile infection in the patient whose disease condition can’t be improved by antibiotic regimen. It also exhibits its therapeutic impact in disease conditions like obesity, irritable bowel syndrome (IBS), metabolic syndrome, inflammatory bowel disease (IBD). In recent studies, research scholar implemented this Microbiota transfer therapy (MTT) in patient with Autism spectrum disorders (ASD) and attained the greater health benefits.